The Chemours Company

The Chemours Company (CC) Market Cap

The Chemours Company has a market capitalization of $3.48B.

Financials based on reported quarter end 2025-12-31

Price: $23.18

-0.69 (-2.89%)

Market Cap: 3.48B

NYSE · time unavailable

CEO: Denise Dignam

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 2015-06-19

Website: https://www.chemours.com

The Chemours Company (CC) - Company Information

Market Cap: 3.48B · Sector: Basic Materials

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Analyst Sentiment

70%
Strong Buy

Based on 9 ratings

Analyst 1Y Forecast: $20.35

Average target (based on 3 sources)

Consensus Price Target

Low

$17

Median

$19

High

$29

Average

$22

Downside: -6.3%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CHEMOURS (CC) — Investment Overview

🧩 Business Model Overview

The Chemours Company (NYSE: CC) is a leading global provider of performance chemicals that are critical to a range of industries, including automotive, construction, electronics, energy, and consumer goods. Formed as a spin-off from DuPont, Chemours operates under a pure-play specialty chemicals model, emphasizing the development, manufacture, and commercialization of value-added chemical products. The company's portfolio is anchored on three main segments: Titanium Technologies, Thermal & Specialized Solutions (formerly Fluoroproducts), and Advanced Performance Materials. Chemours serves more than 3,700 customers in approximately 120 countries, leveraging a diverse product range and a global production footprint to deliver materials essential to everyday life and advanced manufacturing.

💰 Revenue Streams & Monetisation Model

Chemours generates revenue through the sale of specialized chemical products, with operations spanning three core segments: - Titanium Technologies: This segment produces titanium dioxide (TiO₂), a white pigment widely used in paints, coatings, plastics, and paper. TiO₂ is prized for its opacity, brightness, and durability, making it indispensable for premium applications. - Thermal & Specialized Solutions: This division provides fluoroproducts such as refrigerants, propellants, and industrial chemicals, serving sectors including HVAC, refrigeration, automotive, and electronics. The segment also includes next-generation, low Global Warming Potential (GWP) refrigerants under the Opteon® brand. - Advanced Performance Materials: This segment features high-performance polymers and fluoropolymers, notably Teflon™, utilized in semiconductor manufacturing, automotive components, communications, and consumer electronics. Monetization is driven by direct sales to industrial and commercial customers, supported by long-term supply agreements in some markets. Pricing power is often reinforced by technological differentiation and regulatory tailwinds, which can translate into value-based pricing strategies especially in environmentally advanced product lines.

🧠 Competitive Advantages & Market Positioning

Chemours commands competitive advantages rooted in scale, technological innovation, and a robust intellectual property portfolio. The company’s global leadership in TiO₂ and fluoroproducts provides significant economies of scale and entrenched customer relationships. In addition, Chemours holds a leading market share in several product categories, such as titanium dioxide pigment and next-generation refrigerants. A key differentiator is Chemours’ ability to leverage advanced R&D to develop environmentally sustainable solutions — such as low-GWP refrigerants — ahead of regulatory mandates. This proactive approach positions the company as a strategic supplier to global customers navigating shifting environmental standards. Exclusive brands like Ti-Pure™, Opteon®, and Teflon™ confer a high degree of brand equity and customer loyalty, allowing Chemours to defend margins against commodity price swings. Strong manufacturing and distribution capabilities, combined with a focus on operational excellence and safety, further cement its competitive positioning.

🚀 Multi-Year Growth Drivers

Several structural trends support a multi-year growth runway for Chemours: - Global Infrastructure & Urbanization: Growing demand for durable coatings, plastics, and architectural materials bolsters TiO₂ consumption, particularly in emerging economies where urbanization is accelerating. - Environmental Regulations & Next-Generation Refrigerants: Stricter regulations phasing out legacy hydrofluorocarbons (HFCs) in favor of low-GWP refrigerants drive demand for Chemours’ Opteon® portfolio, providing a durable competitive moat. - Electric Vehicles & Electronics: Rising adoption of electric vehicles, 5G infrastructure, and data centers enhances demand for advanced performance materials, especially high-purity fluoropolymers used in batteries and electronics manufacturing. - Innovation in Specialty Chemicals: Ongoing investments in R&D fuel product pipeline expansion, enabling Chemours to address emerging market needs in sustainability, energy efficiency, and digital transformation. - Operational Efficiency: Continuous cost optimization, supply chain enhancements, and capacity expansions contribute to margin improvement and higher free cash flow generation.

⚠ Risk Factors to Monitor

Key risks associated with Chemours’ business model and industry include: - Commodity Price Volatility: The pricing and margin profile of TiO₂ and fluoroproducts are sensitive to raw material costs and global supply-demand dynamics. - Regulatory & Environmental Liabilities: Ongoing litigation and potential liabilities from historical operations (such as legacy environmental remediation) can impact financial performance. - Cyclical End Markets: Exposure to macroeconomic cycles in end-markets like construction, automotive, and industrials introduces volatility to demand. - Technological Disruption: Advances in alternative materials or regulatory shifts could erode product demand or require further investment in innovation. - Leverage & Capital Structure: The use of debt to fund operations and capital returns poses refinancing and liquidity risks, particularly if earnings decline.

📊 Valuation & Market View

Chemours’ valuation typically reflects discounted cash flow prospects linked to earnings volatility in cyclical end-markets and environmental risk overlays. Investors often benchmark Chemours against global peers in the specialty chemicals space based on EBITDA multiples, free cash flow yield, and dividend policy. Relative to historical averages, Chemours’ valuation incorporates both its solid competitive position in core product lines and a risk premium for environmental litigation exposures. The company’s free cash flow orientation supports ongoing shareholder returns through dividends and buybacks, subject to leverage targets and capital allocation discipline. Its capacity to command pricing premiums in differentiated products mitigates some cyclicality risk, while ongoing debt reduction and balance sheet strengthening remain in focus for equity and credit investors alike.

🔍 Investment Takeaway

Chemours represents a focused investment opportunity in the specialty chemicals sector, combining leading global franchises in titanium technologies and fluoroproducts with a proven track record of innovation and operational execution. While cyclical end-markets and regulatory headwinds present ongoing challenges, Chemours’ market leadership, portfolio shift toward environmentally advanced products, and commitment to disciplined capital allocation underpin its potential for resilient cash generation and value creation. Prudent investors should continuously monitor environmental developments, demand trends in key applications, and capital structure evolution when assessing Chemours’ long-term investment merit.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"Headline (latest quarter, 2025-12-31): Revenue of $1.33B and net income of -$61M (EPS -0.40). Over the most recent QoQ sequence, Revenue fell from $1.50B (2025-09-30) to $1.33B (-11.0% QoQ). Net income swung from +$60M to -$61M (down ~-201.7% QoQ). Profitability has been volatile across the 4-quarter period: net margin moved from +4.0% (2025-09-30) to about -4.6% (2025-12-31) after a deep loss in 2025-06-30 (-23.6%). Cash generation looks better than earnings in most quarters: free cash flow was positive in 3 of the last 4 quarters ($92M, $105M, $69M) but deteriorated sharply in 2025-03-31 (-$196M). Dividend payments continued steadily (paid quarterly $0.0875 per share), with dividend yield ~0.85% on 12/31; buybacks are not provided. Balance sheet leverage remains elevated (net debt ~ $3.8–$3.9B), while equity is thin ($251M). On shareholder returns, the stock shows exceptional momentum: +99.9% over 1 year, which materially outweighs the low yield. Analyst consensus target (~$21.71) sits below the current price (~$23.03), suggesting limited upside vs expectations."

Revenue Growth

Caution

Revenue declined -11.0% QoQ (from $1.50B to $1.33B). A 4-quarter YoY comparison is not possible with the provided history.

Profitability

Caution

Earnings are highly volatile: net income swung from +$60M to -$61M QoQ. Net margin contracted from ~+4.0% (2025-09-30) to ~-4.6% (2025-12-31).

Cash Flow Quality

Positive

FCF was positive in 3 of 4 quarters ($92M/$105M/$69M) though it turned sharply negative in 2025-03-31 (-$196M). Dividends were maintained; buybacks not shown.

Leverage & Balance Sheet

Caution

Leverage remains high with net debt ~ $3.8–$3.9B and thin equity ($251M at 2025-12-31). No clear strengthening trend over the period.

Shareholder Returns

Strong

Total return is strongly supported by price momentum: +99.9% 1Y (>20%). Dividend yield is modest (~0.85%), and no buyback data is provided.

Analyst Sentiment & Valuation

Positive

Consensus target ($21.71) is below the current price (~$23.03), implying limited immediate upside, but the stock has outperformed expectations recently.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Management’s tone was confident—reaffirming full-year 2026 guidance “with full confidence” and emphasizing cash normalization after Q4’s cash-flow actions in APM. However, the Q&A revealed the main near-term pressure points are operational and timing-related rather than demand collapse: APM’s Washington Works disruption is explicitly quantified at a -$20M to -$25M earnings impact in Q1 (mostly restricted sales), plus TT is carrying roughly +$17M net costs from inventory/ore mix and low utilization, dragging TT Q1 adjusted EBITDA to breakeven–$5M. The analyst scrutiny focused on the bridge from a $135M Q1 midpoint to a much higher mid-year run-rate; management attributed uplift primarily to (1) seasonality and (2) continued refrigerant/Opteon strength plus TT pricing momentum, with “unusual items” concentrated in Q1 rather than repeating. On a positive note, the $300M Kuan Yin land-sale proceeds and >25% free-cash-flow conversion target support deleveraging to <4x leverage by year-end.

AI IconGrowth Catalysts

  • TSS: Opteon sales record in Q4; double-digit Opteon refrigerant growth of 37% YoY
  • TSS: Annual Opteon refrigerant growth of 56% in 2025; Opteon = 75% of total refrigerant sales vs 56% prior year
  • TT: December pricing actions supporting pricing stability from Q3 to Q4 and laying groundwork for 2026 pricing strength
  • APM: Strength in Performance Solutions demand tied to semiconductor/data center/AI buildout; order book strengthening in January

Business Development

  • TSS commercial progress: qualification of Chemours two-phase liquid cooling solution by Samsung Electronics
  • TSS liquid cooling growth: start of manufacturing agreement with Navin Fluorine targeting initial commercial production in 2026
  • TT: Mike Foley appointed as new Business President of TT
  • Portfolio actions: restructure of TT mining (idled one North Florida mine; shifted to third-party earthmoving contractor)

AI IconFinancial Highlights

  • Q4 cash flow: strong quarterly free cash flow of $92,000,000 (management framed as more reflective of longer-term cash generation)
  • Q4 earnings: APM cash-flow focus led to certain noncash charges and product sales to reduce inventory; management said it 'just missed' the low end of the earnings range
  • TSS margin: annual adjusted EBITDA margins 32% vs 31% prior year (despite ~$22,000,000 additional costs in liquid cooling and next-gen refrigerants R&D)
  • Q1 2026 guidance (consolidated): net sales +3% to +5% sequentially; adjusted EBITDA $121,000,000 to $150,000,000; corporate expenses $45,000,000 to $50,000,000; capital expenditures $50,000,000; free cash flow use of cash not to exceed $100,000,000
  • Q1 2026 APM impact: Washington Works outage expected to create -$20,000,000 to -$25,000,000 (mostly restricted sales) with operations resumed but restart delayed by winter weather
  • Q1 2026 TT: adjusted EBITDA between breakeven and $5,000,000 due to ~+$17,000,000 net costs for inventory/ore mix plus low plant utilization
  • Full-year 2026 guidance (consolidated): net sales growth 3% to 5%; adjusted EBITDA $800,000,000 to $900,000,000; capex $275,000,000 to $325,000,000
  • Full-year 2026 free cash flow: conversion expected above 25%
  • Deleveraging bridge: $300,000,000 estimated net proceeds from Kuan Yin site sale used to reduce debt; net leverage expected below 4x adjusted EBITDA by end of 2026 (milestone toward <3x long-term)

AI IconCapital Funding

  • Planned land sale: estimated net proceeds of $300,000,000 from Kuan Yin facility sale to reduce outstanding debt
  • Net leverage trajectory: below 4.0x adjusted EBITDA by end of 2026
  • Q1 2026 capital expenditures: ~$50,000,000
  • Q1 2026 free cash flow: cash outflow limited to <=$100,000,000

AI IconStrategy & Ops

  • APM: Washington Works disruption traced to equipment impacted by local utility service outage in August; shutdown/restart delays due to challenging winter weather; plant returned to normal operations
  • APM maintenance/timing: turnaround originally planned for early next year pulled forward by taking scope out of the March/period downtime; remaining work described as regular 'tune up' to drive reliable operations
  • TT: mining restructuring began early January (temporary idling of one mine in North Florida; switched to third-party earthmoving contractor) to support cost and cash generation
  • TT operational calibration: production expectations calibrated to anticipated market conditions; focus on cost improvements and cash flow generation
  • TSS: Chemours Business System rollout (lean principles) to reduce waste and increase productivity across the manufacturing circuit
  • TSS: Corpus Christi capacity expansion ramp continues; described as a lower-cost technology platform

AI IconMarket Outlook

  • TSS Q1 2026 net sales: sequential increase in mid-20s to 30% range
  • TSS Q1 2026 Opteon forecast: sequential increase 30% to 40%
  • TSS Q1 2026 adjusted EBITDA: $170,000,000 to $185,000,000
  • TT Q1 2026 net sales: sequential decrease low to mid-single digits percentage range; TiO2 pigment sales down low single digits; mineral sales down 60% sequentially
  • TT Q1 2026 adjusted EBITDA: breakeven to $5,000,000
  • APM Q1 2026 net sales: decrease high-teens percentage range sequentially (market weakness + customer timing + Washington Works outage)
  • APM Q1 2026 adjusted EBITDA: breakeven to $5,000,000 (outage-driven)
  • Consolidated Q1 2026 adjusted EBITDA: $121,000,000 to $150,000,000
  • Management reaffirmed full-year 2026 guide with confidence and highlighted expectation of earnings growth in all three businesses

AI IconRisks & Headwinds

  • APM: Washington Works outage and restart delays—negative $20,000,000 to $25,000,000 in Q1 (mostly restricted sales); operational disruption sensitivity to utility interruptions and winter restart timing
  • APM: near-term end market weakness (auto and industrial construction) described as down to 'flat' but still a cyclically sensitive headwind
  • TT: Q1 ore mix/inventory cost noise—~$17,000,000 of net costs expected tied to inventory and ore mix plus low plant utilization
  • TT: ongoing ore mix/inputs complexity—winter interruption drove need to consume higher-grade ore; one ore contract completed and a second unfavorable contract still being worked through
  • TSS/FX/raw materials: increased raw material costs, primarily R-32 (stationary refrigerants component) partially offsetting cost-out benefits
  • Anti-dumping/competitive dynamics: Brazil cited as having 'really high duties' supporting market for Mexico facility; India described as 'back and forth' with expectation duties will return via process; Europe uplift tempered by currency changes that benefit Chinese producers

Sentiment: MIXED

Note: This summary was synthesized by AI from the CC Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (CC)

© 2026 Stock Market Info — The Chemours Company (CC) Financial Profile